Pneumococcal Conjugate Vaccine in Healthy Infants (B7471013)

A phase 3, randomized, double-blind trial to evaluate the safety of a 20-valent pneumococcal conjugate vaccine in healthy infants at investigator sites in the United States and potentially other countries to be determined. This study is part of the Phase 3 clinical development program to support the use of 20vPnC in the pediatric population. The…

Pediatric Pneumococcal Vaccine (PSK00008)

A Phase II, randomized, observer-blind, controlled, age de-escalation study in approximately 140 toddlers and 700 infants in the US and Canada. This study is to asses the Safety and Immunogenicity of a Pheumococcal Conjugate Vaccine when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Toddlers Infants. Register Today!.